Implications of Tioguanine Dosing in IBD Patients with a TPMT Deficiency
Debbie S. Deben, Dennis R. Wong(Zuyderland Medisch Centrum), B.J.C. van den Bosch(Maastricht University Medical Centre), Adriaan A. van Bodegraven(Maastricht University Medical Centre), Luc J. J. Derijks(Radboud University Nijmegen), Rob H. Creemers(Zuyderland Medisch Centrum), A. Van Nunen(Zuyderland Medisch Centrum)
Cited by 1
Related Papers
Drug Insight: pharmacology and toxicity of thiopurine therapy in patients with IBD
|Nature Clinical Practice Gastroenterology & Hepatology|2007|129
Safety and Effectiveness of Long-term Allopurinol–Thiopurine Maintenance Treatment in Inflammatory Bowel Disease
|Inflammatory Bowel Diseases|2012|102
Dose-Dependent Influence of 5-Aminosalicylates on Thiopurine Metabolism
|The American Journal of Gastroenterology|2007|101
Thiopurines in Inflammatory Bowel Disease: New Findings and Perspectives
|Journal of Crohn s and Colitis|2017|94
Tofacitinib for ulcerative colitis: results of the prospective Dutch Initiative on Crohn and Colitis (ICC) registry
|Alimentary Pharmacology & Therapeutics|2020|87